Rating Change
UBS analysts initiated coverage on ATRenew Inc. (NYSE:RERE) with a Buy rating on July 21, 2026.
Rating Change UBS analysts initiated coverage on ATRenew Inc. (NYSE:RERE) with a Buy rating on July 21, 2026. Market Context ATRenew Inc.

UBS analysts initiated coverage on ATRenew Inc. (NYSE:RERE) with a Buy rating on July 21, 2026.
ATRenew Inc. operates in the Consumer Cyclical sector. The stock currently trades at $3.94 with a market capitalization of $1.9B. The stock has gained 8.5% over the past 52 weeks.
Analyst coverage from UBS provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for ATRenew Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 3 most recent ratings: 3 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 21, 2026 | UBS | Buy | N/A |
| Jul 15, 2021 | B of A Securities | Buy | N/A |
| Jul 14, 2021 | Goldman Sachs | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View RERE Stock Page
A Buy rating from UBS reflects the analyst's outlook on ATRenew Inc. (NYSE:RERE). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the RERE forecast page.
Current market data
NYSE · RERE
$4.04
Down: -$0.06 · -1.49%
Live quote updated
Keep reading